Skip to main content
Top
Gepubliceerd in: Quality of Life Research 4/2014

01-05-2014 | Brief Communication

Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse

Auteurs: Alberto Raggi, Ambra Mara Giovannetti, Silvia Schiavolin, Matilde Leonardi, Gennaro Bussone, Licia Grazzi, Susanna Usai, Marcella Curone, Paola Di Fiore, Domenico D’Amico

Gepubliceerd in: Quality of Life Research | Uitgave 4/2014

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

The purpose of the study is to assess validity, reliability and factor structure of the Italian version of Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in patients suffering from chronic migraine (CM) with a history of medication overuse (MO).

Methods

Patients were enroled at hospital admission for withdrawal from MO. Factor analysis was used to confirm the latent structure of the MSQ. Reliability was measured with Cronbach’s alpha coefficient, item-total correlation and inter-item correlation. Construct validity was assessed with Pearson’s coefficient and known-group analysis.

Results

The three-factor structure is basically confirmed. Cronbach’s alpha varied between 0.85 and 0.92; item-total correlations were on average higher than 0.70; average inter-item correlation ranged between 0.63 and 0.65. Correlations were all significant; known-group analysis shows that MSQ score was lower consistently with disease severity.

Conclusions

Our findings confirm the factor structure, reliability and validity of the MSQ and expand results of previous validation studies to the Italian language and to a group of patients with severe CM requiring withdrawal treatment for MO.
Literatuur
1.
go back to reference Stovner, L. J., Zwart, J. A., Hagen, K., Terwindt, G. M., & Pascual, J. (2006). Epidemiology of headache in Europe. European Journal of Neurology, 13(4), 333–345.PubMedCrossRef Stovner, L. J., Zwart, J. A., Hagen, K., Terwindt, G. M., & Pascual, J. (2006). Epidemiology of headache in Europe. European Journal of Neurology, 13(4), 333–345.PubMedCrossRef
2.
go back to reference Linde, M., Gustavsson, A., Stovner, L. J., Steiner, T. J., Barré, J., Katsarava, Z., et al. (2012). The cost of headache disorders in Europe: The Eurolight project. European Journal of Neurology, 19(5), 703–711.PubMedCrossRef Linde, M., Gustavsson, A., Stovner, L. J., Steiner, T. J., Barré, J., Katsarava, Z., et al. (2012). The cost of headache disorders in Europe: The Eurolight project. European Journal of Neurology, 19(5), 703–711.PubMedCrossRef
3.
go back to reference Bigal, M. E., & Lipton, R. B. (2011). Migraine chronification. Current Neurology and Neuroscience Reports, 11(2), 139–148.PubMedCrossRef Bigal, M. E., & Lipton, R. B. (2011). Migraine chronification. Current Neurology and Neuroscience Reports, 11(2), 139–148.PubMedCrossRef
4.
go back to reference Bigal, M. E., Serrano, D., Buse, D., Scher, A., Stewart, W. F., & Lipton, R. B. (2008). Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache, 48(8), 1157–1168.PubMedCrossRef Bigal, M. E., Serrano, D., Buse, D., Scher, A., Stewart, W. F., & Lipton, R. B. (2008). Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache, 48(8), 1157–1168.PubMedCrossRef
5.
go back to reference Castillo, J., Munoz, P., Guitera, V., & Pascual, J. (1999). Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache, 39(3), 190–196. Castillo, J., Munoz, P., Guitera, V., & Pascual, J. (1999). Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache, 39(3), 190–196.
6.
go back to reference Natoli, J. L., Manack, A., Dean, B., Butler, Q., Turkel, C. C., Stovner, L., et al. (2010). Global prevalence of chronic migraine: A systematic review. Cephalalgia, 30(5), 599–609.PubMed Natoli, J. L., Manack, A., Dean, B., Butler, Q., Turkel, C. C., Stovner, L., et al. (2010). Global prevalence of chronic migraine: A systematic review. Cephalalgia, 30(5), 599–609.PubMed
7.
go back to reference Lipton, R. B. (2009). Tracing transformation: Chronic migraine classification, progression, and epidemiology. Neurology, 72(Suppl 5), S3–S7.PubMedCrossRef Lipton, R. B. (2009). Tracing transformation: Chronic migraine classification, progression, and epidemiology. Neurology, 72(Suppl 5), S3–S7.PubMedCrossRef
8.
go back to reference Raggi, A., Giovannetti, A. M., Leonardi, M., Schiavolin, S., D’Amico, D., Curone, M., et al. (2012). Disability and mood state in patients with episodic and chronic migraine associated to medication overuse. Neurological Sciences, 33(Suppl 1), S169–S171.PubMedCrossRef Raggi, A., Giovannetti, A. M., Leonardi, M., Schiavolin, S., D’Amico, D., Curone, M., et al. (2012). Disability and mood state in patients with episodic and chronic migraine associated to medication overuse. Neurological Sciences, 33(Suppl 1), S169–S171.PubMedCrossRef
9.
go back to reference D’Amico, D., Grazzi, L., Usai, S., Raggi, A., Leonardi, M., & Bussone, G. (2011). Disability in chronic daily headache: State of the art and future directions. Neurological Sciences, 32(Suppl 1), 71–76.CrossRef D’Amico, D., Grazzi, L., Usai, S., Raggi, A., Leonardi, M., & Bussone, G. (2011). Disability in chronic daily headache: State of the art and future directions. Neurological Sciences, 32(Suppl 1), 71–76.CrossRef
10.
go back to reference Bigal, M. E., Rapoport, A. M., Lipton, R. B., Tepper, S. J., & Sheftell, F. D. (2003). Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: A comparison of chronic migraine with episodic migraine. Headache, 43(4), 336–342.PubMedCrossRef Bigal, M. E., Rapoport, A. M., Lipton, R. B., Tepper, S. J., & Sheftell, F. D. (2003). Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: A comparison of chronic migraine with episodic migraine. Headache, 43(4), 336–342.PubMedCrossRef
11.
go back to reference Sanders, C., Egger, M., Donovan, J., Tallon, D., & Frankel, S. (1998). Reporting on quality of life in randomised controlled trials: Bibliographic study. British Medical Journal, 317(7167), 1191–1194.PubMedCentralPubMedCrossRef Sanders, C., Egger, M., Donovan, J., Tallon, D., & Frankel, S. (1998). Reporting on quality of life in randomised controlled trials: Bibliographic study. British Medical Journal, 317(7167), 1191–1194.PubMedCentralPubMedCrossRef
12.
go back to reference Fitzpatrick, R., Davey, C., Buxton, M.J. & Jones, D.R. (1998). Evaluating patient-based outcome measures for use in clinical trials. Health Technology Assessment, 2(14), i–iv, 1–74. Fitzpatrick, R., Davey, C., Buxton, M.J. & Jones, D.R. (1998). Evaluating patient-based outcome measures for use in clinical trials. Health Technology Assessment, 2(14), i–iv, 1–74.
13.
go back to reference Tfelt-Hansen, P., Block, G., Dahlof, C., Diener, H. C., Ferrari, M. D., Goadsby, P. J., et al. (2000). Guidelines for controlled trials of drugs in migraine: Second edition. Cephalalgia, 20(9), 765–786.PubMedCrossRef Tfelt-Hansen, P., Block, G., Dahlof, C., Diener, H. C., Ferrari, M. D., Goadsby, P. J., et al. (2000). Guidelines for controlled trials of drugs in migraine: Second edition. Cephalalgia, 20(9), 765–786.PubMedCrossRef
14.
go back to reference Silberstein, S., Tfelt-Hansen, P., Dodick, D. W., Limmroth, V., Lipton, R. B., Pascual, J., et al. (2008). Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia, 28(5), 484–495.PubMedCrossRef Silberstein, S., Tfelt-Hansen, P., Dodick, D. W., Limmroth, V., Lipton, R. B., Pascual, J., et al. (2008). Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia, 28(5), 484–495.PubMedCrossRef
15.
go back to reference Martin, B. C., Pathak, D. S., Sharfman, M. I., Adelman, J. U., Taylor, F., Kwong, W. J., et al. (2000). Validity and reliability of the Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1). Headache, 40(3), 204–215.PubMedCrossRef Martin, B. C., Pathak, D. S., Sharfman, M. I., Adelman, J. U., Taylor, F., Kwong, W. J., et al. (2000). Validity and reliability of the Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1). Headache, 40(3), 204–215.PubMedCrossRef
16.
go back to reference Lipton, R. B., Varon, S. F., Grosberg, B., McAllister, P. J., Freitag, F., Aurora, S. K., et al. (2011). OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine. Neurology, 77(15), 1465–1472.PubMedCrossRef Lipton, R. B., Varon, S. F., Grosberg, B., McAllister, P. J., Freitag, F., Aurora, S. K., et al. (2011). OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine. Neurology, 77(15), 1465–1472.PubMedCrossRef
17.
go back to reference Cole, J. C., Lin, P., & Rupnow, M. F. (2009). Minimal important differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) version. Cephalalgia, 29(11), 1180–1187.PubMedCrossRef Cole, J. C., Lin, P., & Rupnow, M. F. (2009). Minimal important differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) version. Cephalalgia, 29(11), 1180–1187.PubMedCrossRef
18.
go back to reference Bagley, C. L., Rendas-Baum, R., Maglinte, G. A., Yang, M., Varon, S. F., Lee, J., et al. (2012). Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache, 52(3), 409–421.PubMedCrossRef Bagley, C. L., Rendas-Baum, R., Maglinte, G. A., Yang, M., Varon, S. F., Lee, J., et al. (2012). Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache, 52(3), 409–421.PubMedCrossRef
19.
go back to reference Rendas-Baum, R., Bloudek, L. M., Maglinte, G. A., & Varon, S. F. (2013). The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients. Quality of Life Research, 22(5), 1123–1133.PubMedCentralPubMedCrossRef Rendas-Baum, R., Bloudek, L. M., Maglinte, G. A., & Varon, S. F. (2013). The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients. Quality of Life Research, 22(5), 1123–1133.PubMedCentralPubMedCrossRef
20.
go back to reference Silberstein, S. D., Lipton, R. B., & Sliwinski, M. (1996). Classification of daily and near-daily headaches: Field trial of revised IHS criteria. Neurology, 47(4), 871–875.PubMedCrossRef Silberstein, S. D., Lipton, R. B., & Sliwinski, M. (1996). Classification of daily and near-daily headaches: Field trial of revised IHS criteria. Neurology, 47(4), 871–875.PubMedCrossRef
21.
go back to reference Ustun, T. B., Chatterji, S., Kostanjsek, N., Rehm, J., Kennedy, C., Epping-Jordan, J., et al. (2010). Developing the World Health Organization Disability Assessment Schedule 2.0. Bulletin of the World Health Organization, 88(11), 815–823.PubMedCentralPubMedCrossRef Ustun, T. B., Chatterji, S., Kostanjsek, N., Rehm, J., Kennedy, C., Epping-Jordan, J., et al. (2010). Developing the World Health Organization Disability Assessment Schedule 2.0. Bulletin of the World Health Organization, 88(11), 815–823.PubMedCentralPubMedCrossRef
22.
go back to reference Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the Beck Depression Inventory-II. San Antonio: Psychological Corporation. Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the Beck Depression Inventory-II. San Antonio: Psychological Corporation.
23.
go back to reference D’Amico, D., Mosconi, P., Genco, S., Usai, S., Prudenzano, A. M., Grazzi, L., et al. (2001). The Migraine Disability Assessment (MIDAS) questionnaire: Translation and reliability of the Italian version. Cephalalgia, 21(10), 947–952.PubMedCrossRef D’Amico, D., Mosconi, P., Genco, S., Usai, S., Prudenzano, A. M., Grazzi, L., et al. (2001). The Migraine Disability Assessment (MIDAS) questionnaire: Translation and reliability of the Italian version. Cephalalgia, 21(10), 947–952.PubMedCrossRef
24.
go back to reference Headache Classification Subcommittee of the International Headache Society. (2004). The international classification of headache disorders: 2nd edition. Cephalalgia, 24(Suppl 1), 9–160. Headache Classification Subcommittee of the International Headache Society. (2004). The international classification of headache disorders: 2nd edition. Cephalalgia, 24(Suppl 1), 9–160.
25.
go back to reference Cevoli, S., D’Amico, D., Martelletti, P., Valguarnera, F., Del Bene, E., De Simone, R., et al. (2009). Underdiagnosis and undertreatment of migraine in Italy: A survey of patients attending for the first time 10 headache centres. Cephalalgia, 29(12), 1285–1293.PubMedCrossRef Cevoli, S., D’Amico, D., Martelletti, P., Valguarnera, F., Del Bene, E., De Simone, R., et al. (2009). Underdiagnosis and undertreatment of migraine in Italy: A survey of patients attending for the first time 10 headache centres. Cephalalgia, 29(12), 1285–1293.PubMedCrossRef
Metagegevens
Titel
Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse
Auteurs
Alberto Raggi
Ambra Mara Giovannetti
Silvia Schiavolin
Matilde Leonardi
Gennaro Bussone
Licia Grazzi
Susanna Usai
Marcella Curone
Paola Di Fiore
Domenico D’Amico
Publicatiedatum
01-05-2014
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 4/2014
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-013-0556-9

Andere artikelen Uitgave 4/2014

Quality of Life Research 4/2014 Naar de uitgave